Drug Profile
AZD 6280
Alternative Names: AZD6280Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Anxiolytics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 29 Jul 2010 Discontinued - Phase-I for Anxiety disorders in United Kingdom (unspecified route)
- 07 Dec 2007 Phase-I clinical trials in Anxiety disorders in United Kingdom (unspecified route)